| Prev Close | 51.91 |
| Open | 51.86 |
| Day Low/High | 51.82 / 53.09 |
| 52 Wk Low/High | 37.29 / 64.90 |
| Volume | 2.89M |
Lennar Corporation Class A (LEN)
52.91
1.00
1.93
NYSE
| Exchange | NYSE |
| Shares Outstanding | 323.18B |
| Market Cap | 16.78B |
| Div & Yield | N.A. (N.A) |
At the Bandstand
"Let's be very careful out there." - Sgt. Esterhaus, Hill Street Blues Markets closed near the day's lows - completing a four-day losing streak for the S&P Index. Downside leadership was seen in banks (contagion concerns rather than rate concerns...
Redfin Might Be the Canary in the Housing Coal Mine… or Not: Market Recon
The housing always has been regional, which makes it dicey to judge where it is headed from any one company.
Jim Cramer: 6 Stocks That Mr. 'Anti-FANG' Loves
From Citigroup to Ford, these names look great.
Jim Cramer: A Pretty Wild Rally In Three Oppositional Groups
How can this be? Let's take a look at the camps so we can figure it out.
Here Are 3 Homebuilders Doing Well
Average selling price of homes continues to post mid-single year-over-year gains across the industry.
GE to Exit Healthcare Business and 4 Other Stories to Watch Premarket Tuesday
These are the stories moving the market ahead of Tuesday's opening bell.
3 Stocks to Buy on the Market's Dip (and 1 to Write a Call On): Market Recon
And don't forget your target prices and panic points.
Jim Cramer: A GLUM Index For Gloomy Markets
Taking the measure of what's keeping the markets in the dumps.
Lennar Back Down to $50
More risk lies ahead for home builder.
Jim Cramer: The Playbook Says You Have to Sell the Homebuilder Stocks
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer discussed how the rising 10-year Treasury yield is wreaking havoc on the homebuilder stocks in a Thursday column on Real Money.
Jim Cramer: Homebuilder, Consumer Packaged Goods Stocks Face the 'New' Bad
These stocks are like spewing volcanoes. You do not want to get hit by one of them.
Closing Bell: LIVE MARKETS BLOG
U.S. markets had a strong day of trading Wednesday, closing the day in the green across the board.
Jim Cramer: Repeal of All of the Gains We Are Seeing Makes No Real Sense
The idea that the tax changes have done nothing is, indeed, fanciful.
Novice Trade: ITB Home Construction ETF
A bullishly biased, ITB out-of-the-money long call 'shooter' expiring in July.
4 Stocks You Should Be Watching This Earnings Season
Here are some smaller names I have my eye on as the season heats up.
Watch These 4 Stocks This Earnings Season
Here are some smaller names I have my eye on.
Lennar Is One of 6 Stocks Poised to Change Direction
These names are showing technical characteristics of either bullish or bearish reversal patterns over the past week.
15 Sectors to Buy on a U.S./Chinese Trade War (Part II)
Seven more areas that you should buy on a dip any time trade jitters take the market down.
Jim Cramer: What to Look for In Friday's Non-Farm Employment Report
The labor participation rate, and not the employment number itself, may be the key 8:30 a.m. figure.
Jim Cramer: Markets Seek Domestic Tranquility
Stock markets ran higher as investors turned towards domestic-focused companies.
Two to Buy on the Dip
Talk of intensifying trade war is creating some bargains for investors.
Trade War! Game On: Market Recon
If you went to bed net long the stock market, there's a pretty good chance you're going to wake up deep in a hole.
The Tech Sector Takes a Beating: Market Recon
Most of the economy has become reliant to some degree...on technology.
Intermediate Trade: Home Construction ETF
Spring begins the home-buying season, and spring begins two weeks from tomorrow.
Video: Jim Cramer on Walmart, Delta Air Lines, Lennar, KB Home and Netflix
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Thursday's trending stocks.
Jim Cramer on Delta Airlines, Lennar and KB Home's Earnings
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer reacts to the start of fourth quarter earnings season.
Biotech Shows Strength
The major indices have improved a tad since our last update. Biotech has shown some strength over the past two hours or so. There are two names to keep an eye on: T2 Biosystems has been strong so far in 2018, moving from around $4 to over $5 a shar...
Running for the Hills? Some Bond Traders Are: Market Recon
Treasuries have clearly started to sell off in the deep end of the pool.
